Global Anterior Uveitis Drug Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028

Published on: 2022-01-10 | No of Pages : 320 | Industry : Pharma & Healthcare

Publisher : GRD Survey | Format : PDF

Global Anterior Uveitis Drug Industry Outlook 2022: Overview, Opportunities, Key Companies and Forecast to 2028

Executive Summary

According to GRD Survey data, the global Anterior Uveitis Drug market is estimated at million US$ in 2021 and is expected to reach million US$ by the end of 2028, growing at a CAGR of % in the forecast period between 2022 and 2028.

This report studies the Anterior Uveitis Drug market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Anterior Uveitis Drug in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Dalazatide
LME-636
NOP-3
Others

Market Snapshot, By Application
Clinic
Hospital
Others

Main Market Players Analyzed in this report, including:
Neuroptis Biotech
KPI Therapeutics, Inc.
EyeGate Pharmaceuticals, Inc.
Aldeyra Therapeutics, Inc.
Aciont Inc.

The study objectives of this report are:
To study and analyze the global Anterior Uveitis Drug market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Anterior Uveitis Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Anterior Uveitis Drug manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Anterior Uveitis Drug market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Anterior Uveitis Drug submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Anterior Uveitis Drug are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Content

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Anterior Uveitis Drug Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Anterior Uveitis Drug Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Anterior Uveitis Drug

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Anterior Uveitis Drug Sales Channel and Distributors Analysis
3.3.1 Anterior Uveitis Drug Sales Channel
3.3.2 Anterior Uveitis Drug Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Clinic
3.4.2 Major Buyers in Hospital
3.5 Anterior Uveitis Drug Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 Anterior Uveitis Drug Type Introduction
4.1.1 Dalazatide
4.1.2 LME-636
4.1.3 NOP-3
4.1.4 Others
4.2 Global Anterior Uveitis Drug Sales by Type 2016-2021
4.3 Global Anterior Uveitis Drug Revenue by Type 2016-2021
4.4 Global Anterior Uveitis Drug Price by Type 2016-2021

5 Market Segment: by Application
5.1 Anterior Uveitis Drug Type Introduction
5.1.1 Clinic
5.1.2 Hospital
5.1.3 Others
5.2 Global Anterior Uveitis Drug Sales by Application 2016-2021
5.3 Global Anterior Uveitis Drug Revenue by Application 2016-2021
5.4 Global Anterior Uveitis Drug Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Anterior Uveitis Drug Market by Region
6.1.1 Global Anterior Uveitis Drug Sales by Regions
6.1.2 Global Anterior Uveitis Drug Revenue by Regions
6.2 North America Anterior Uveitis Drug Market 2016-2021
6.3 Europe Anterior Uveitis Drug Market 2016-2021
6.4 Asia Pacific Anterior Uveitis Drug Market 2016-2021
6.5 South America Anterior Uveitis Drug Market 2016-2021
6.6 Middle East and Africa Anterior Uveitis Drug Market 2016-2021

7 North America
7.1 North America Anterior Uveitis Drug Market by Country 2016-2021
7.1.1 North America Anterior Uveitis Drug Sales by Country
7.1.2 North America Anterior Uveitis Drug Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Anterior Uveitis Drug Market by Country 2016-2021
8.1.1 Europe Anterior Uveitis Drug Sales by Country
8.1.2 Europe Anterior Uveitis Drug Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Anterior Uveitis Drug Market by Country 2016-2021
9.1.1 Asia Pacific Anterior Uveitis Drug Sales by Country
9.1.2 Asia Pacific Anterior Uveitis Drug Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Anterior Uveitis Drug Market by Country 2016-2021
10.1.1 South America Anterior Uveitis Drug Sales by Country
10.1.2 South America Anterior Uveitis Drug Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Anterior Uveitis Drug Market by Country 2016-2021
11.1.1 Middle East and Africa Anterior Uveitis Drug Sales by Country
11.1.2 Middle East and Africa Anterior Uveitis Drug Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Neuroptis Biotech
12.1.1 Neuroptis Biotech Company Information
12.1.2 Neuroptis Biotech Anterior Uveitis Drug Product Portfolio, Specification and Application
12.1.3 Neuroptis Biotech Anterior Uveitis Drug Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Neuroptis Biotech Key Development
12.2 KPI Therapeutics, Inc.
12.2.1 KPI Therapeutics, Inc. Company Information
12.2.2 KPI Therapeutics, Inc. Anterior Uveitis Drug Product Portfolio, Specification and Application
12.2.3 KPI Therapeutics, Inc. Anterior Uveitis Drug Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 KPI Therapeutics, Inc. Key Development
12.3 EyeGate Pharmaceuticals, Inc.
12.3.1 EyeGate Pharmaceuticals, Inc. Company Information
12.3.2 EyeGate Pharmaceuticals, Inc. Anterior Uveitis Drug Product Portfolio, Specification and Application
12.3.3 EyeGate Pharmaceuticals, Inc. Anterior Uveitis Drug Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 EyeGate Pharmaceuticals, Inc. Key Development
12.4 Aldeyra Therapeutics, Inc.
12.4.1 Aldeyra Therapeutics, Inc. Company Information
12.4.2 Aldeyra Therapeutics, Inc. Anterior Uveitis Drug Product Portfolio, Specification and Application
12.4.3 Aldeyra Therapeutics, Inc. Anterior Uveitis Drug Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Aldeyra Therapeutics, Inc. Key Development
12.5 Aciont Inc.
12.5.1 Aciont Inc. Company Information
12.5.2 Aciont Inc. Anterior Uveitis Drug Product Portfolio, Specification and Application
12.5.3 Aciont Inc. Anterior Uveitis Drug Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Aciont Inc. Key Development

13 Global Anterior Uveitis Drug Market Forecast by Region by Type and by Application
13.1 Global Anterior Uveitis Drug Sales, Revenue Forecast 2022-2027
13.2 Global Anterior Uveitis Drug Forecast by Regions
13.2.1 Global Anterior Uveitis Drug Sales Forecast by Region 2022-2027
13.2.2 Global Anterior Uveitis Drug Revenue Forecast by Region 2022-2027
13.3 Global Anterior Uveitis Drug Forecast by Type
13.3.1 Global Anterior Uveitis Drug Sales Forecast by Type 2022-2027
13.3.2 Global Anterior Uveitis Drug Revenue Forecast by Type 2022-2027
13.3.3 Global Anterior Uveitis Drug Price Forecast by Type 2022-2027
13.4 Global Anterior Uveitis Drug Forecast by Application
13.4.1 Global Anterior Uveitis Drug Sales Forecast by Application 2022-2027
13.4.2 Global Anterior Uveitis Drug Revenue Forecast by Application 2022-2027
13.4.3 Global Anterior Uveitis Drug Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions

15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer

List of Figure

List of Tables

Table 1: Global Anterior Uveitis Drug Production Specifications
Table 2: Drivers in Anterior Uveitis Drug Market
Table 3: Restraints Anterior Uveitis Drug Market
Table 4: Opportunity in Anterior Uveitis Drug Market
Table 5: Comparion of Alternative and Anterior Uveitis Drug
Table 6: Anterior Uveitis Drug Raw Materials Key Suppliers List
Table 7: Anterior Uveitis Drug Distributors List
Table 8: Anterior Uveitis Drug Major Buyers in Clinic
Table 9: Anterior Uveitis Drug Major Buyers in Hospital
Table 10: Anterior Uveitis Drug Major Buyers in Others
Table 11: Global Anterior Uveitis Drug Sales (K Units) by Type 2016-2021
Table 12: Global Anterior Uveitis Drug Sales Market Share by Type 2016-2021
Table 13: Global Anterior Uveitis Drug Revenue (Million USD) by Type 2016-2021
Table 14: Global Anterior Uveitis Drug Revenue Market Share by Type 2016-2021
Table 15: Global Anterior Uveitis Drug Price by Type 2016-2021
Table 16: Global Anterior Uveitis Drug Sales (K Units) by Application 2016-2021
Table 17: Global Anterior Uveitis Drug Sales Market Share by Application 2016-2021
Table 18: Global Anterior Uveitis Drug Revenue (Million USD) by Application 2016-2021
Table 19: Global Anterior Uveitis Drug Revenue Market Share by Application 2016-2021
Table 20: Global Anterior Uveitis Drug Price by Application 2016-2021
Table 21: Global Anterior Uveitis Drug Sales (K Units) by Region 2016-2021
Table 22: Global Anterior Uveitis Drug Sales Market Share by Region 2016-2021
Table 23: Global Anterior Uveitis Drug Revenue (Million USD) by Region 2016-2021
Table 24: Global Anterior Uveitis Drug Revenue Market Share by Region 2016-2021
Table 25: North America Anterior Uveitis Drug Sales (K Units) by Country 2016-2021
Table 26: North America Anterior Uveitis Drug Sales Market Share by Country 2016-2021
Table 27: North America Anterior Uveitis Drug Revenue (Million USD) by Country 2016-2021
Table 28: North America Anterior Uveitis Drug Revenue Market Share by Country 2016-2021)
Table 29: Europe Anterior Uveitis Drug Sales (K Units) by Country 2016-2021
Table 30: Europe Anterior Uveitis Drug Sales Market Share by Country 2016-2021
Table 31: Europe Anterior Uveitis Drug Revenue (Million USD) by Country 2016-2021
Table 32: Europe Anterior Uveitis Drug Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific Anterior Uveitis Drug Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific Anterior Uveitis Drug Sales Market Share by Country 2016-2021
Table 35: Asia Pacific Anterior Uveitis Drug Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific Anterior Uveitis Drug Revenue Market Share by Country 2016-2021)
Table 37: South America Anterior Uveitis Drug Sales (K Units) by Country 2016-2021
Table 38: South America Anterior Uveitis Drug Sales Market Share by Country 2016-2021
Table 39: South America Anterior Uveitis Drug Revenue (Million USD) by Country 2016-2021
Table 40: South America Anterior Uveitis Drug Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa Anterior Uveitis Drug Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa Anterior Uveitis Drug Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa Anterior Uveitis Drug Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa Anterior Uveitis Drug Revenue Market Share by Country 2016-2021)
Table 45 Neuroptis Biotech Company Information
Table 46 Neuroptis Biotech Anterior Uveitis Drug Product Portfolio, Specification and Application
Table 47 Neuroptis Biotech Anterior Uveitis Drug Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 KPI Therapeutics, Inc. Company Information
Table 49 KPI Therapeutics, Inc. Anterior Uveitis Drug Product Portfolio, Specification and Application
Table 50 KPI Therapeutics, Inc. Anterior Uveitis Drug Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 EyeGate Pharmaceuticals, Inc. Company Information
Table 52 EyeGate Pharmaceuticals, Inc. Anterior Uveitis Drug Product Portfolio, Specification and Application
Table 53 EyeGate Pharmaceuticals, Inc. Anterior Uveitis Drug Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 Aldeyra Therapeutics, Inc. Company Information
Table 55 Aldeyra Therapeutics, Inc. Anterior Uveitis Drug Product Portfolio, Specification and Application
Table 56 Aldeyra Therapeutics, Inc. Anterior Uveitis Drug Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 Aciont Inc. Company Information
Table 58 Aciont Inc. Anterior Uveitis Drug Product Portfolio, Specification and Application
Table 59 Aciont Inc. Anterior Uveitis Drug Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Anterior Uveitis Drug Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global Anterior Uveitis Drug Sales Market Share Forecast by Region (2012-2027)
Table 74: Global Anterior Uveitis Drug Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global Anterior Uveitis Drug Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global Anterior Uveitis Drug Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global Anterior Uveitis Drug Sales Market Share Forecast by Type (2012-2027)
Table 78: Global Anterior Uveitis Drug Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global Anterior Uveitis Drug Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global Anterior Uveitis Drug Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global Anterior Uveitis Drug Sales Market Share Forecast by Application (2012-2027)
Table 82: Global Anterior Uveitis Drug Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global Anterior Uveitis Drug Revenue Market Share Forecast by Application (2022-2027)


List of Figures

Figure 1: Anterior Uveitis Drug Picture
Figure 2: Global Anterior Uveitis Drug Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Anterior Uveitis Drug Supply Chain Analysis
Figure 5: Anterior Uveitis Drug Manufacturing Cost Structure Analysis
Figure 6: Product Picture of Dalazatide
Figure 7: Product Picture of LME-636
Figure 8: Global Anterior Uveitis Drug Sales Market Share by Type, 2020
Figure 9: Global Anterior Uveitis Drug Revenue Market Share by Type, 2020
Figure 10: Anterior Uveitis Drug in Clinic
Figure 11: Global Anterior Uveitis Drug Market: Clinic 2016-2021
Figure 12: Anterior Uveitis Drug in Hospital
Figure 13: Global Anterior Uveitis Drug Market: Hospital 2016-2021
Figure 14: Global Anterior Uveitis Drug Sales Market Share by Application, 2020
Figure 15: Global Anterior Uveitis Drug Revenue Market Share by Application, 2020
Figure 16: Global Anterior Uveitis Drug Sales Market Share by Region 2016-2021
Figure 17: Global Anterior Uveitis Drug Revenue Market Share by Region 2016-2021
Figure 18: North America Anterior Uveitis Drug Sales (K Units) Status 2016-2021
Figure 19: North America Anterior Uveitis Drug Revenue (Million USD) Status 2016-2021
Figure 20: Europe Anterior Uveitis Drug Sales (K Units) Status 2016-2021
Figure 21: Europe Anterior Uveitis Drug Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Anterior Uveitis Drug Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific Anterior Uveitis Drug Revenue (Million USD) Status 2016-2021
Figure 24: South America Anterior Uveitis Drug Sales (K Units) Status 2016-2021
Figure 25: South America Anterior Uveitis Drug Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa Anterior Uveitis Drug Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa Anterior Uveitis Drug Revenue (Million USD) Status 2016-2021
Figure 28: North America Anterior Uveitis Drug Sales Market Share by Country, 2020
Figure 29: North America Anterior Uveitis Drug Revenue Market Share by Country, 2020
Figure 30: United States Anterior Uveitis Drug Sales (K Units) Status 2016-2021
Figure 31: United States Anterior Uveitis Drug Revenue (Million USD) Status 2016-2021
Figure 32: Canada Anterior Uveitis Drug Sales (K Units) Status 2016-2021
Figure 33: Canada Anterior Uveitis Drug Revenue (Million USD) Status 2016-2021
Figure 34: Mexico Anterior Uveitis Drug Sales (K Units) Status 2016-2021
Figure 35: Mexico Anterior Uveitis Drug Revenue (Million USD) Status 2016-2021
Figure 36: Europe Anterior Uveitis Drug Sales Market Share by Country, 2020
Figure 37: Europe Anterior Uveitis Drug Revenue Market Share by Country, 2020
Figure 38: Germany Anterior Uveitis Drug Sales (K Units) Status 2016-2021
Figure 39: Germany Anterior Uveitis Drug Revenue (Million USD) Status 2016-2021
Figure 40: France Anterior Uveitis Drug Sales (K Units) Status 2016-2021
Figure 41: France Anterior Uveitis Drug Revenue (Million USD) Status 2016-2021
Figure 42: UK Anterior Uveitis Drug Sales (K Units) Status 2016-2021
Figure 43: UK Anterior Uveitis Drug Revenue (Million USD) Status 2016-2021
Figure 44: Italy Anterior Uveitis Drug Sales (K Units) Status 2016-2021
Figure 45: Italy Anterior Uveitis Drug Revenue (Million USD) Status 2016-2021
Figure 46: Russia Anterior Uveitis Drug Sales (K Units) Status 2016-2021
Figure 46: Russia Anterior Uveitis Drug Revenue (Million USD) Status 2016-2021
Figure 47: Spain Anterior Uveitis Drug Sales (K Units) Status 2016-2021
Figure 48: Spain Anterior Uveitis Drug Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific Anterior Uveitis Drug Sales Market Share by Country, 2020
Figure 50: Asia Pacific Anterior Uveitis Drug Revenue Market Share by Country, 2020
Figure 51: China Anterior Uveitis Drug Sales (K Units) Status 2016-2021
Figure 52: China Anterior Uveitis Drug Revenue (Million USD) Status 2016-2021
Figure 53: Japan Anterior Uveitis Drug Sales (K Units) Status 2016-2021
Figure 54: Japan Anterior Uveitis Drug Revenue (Million USD) Status 2016-2021
Figure 55: Korea Anterior Uveitis Drug Sales (K Units) Status 2016-2021
Figure 56: Korea Anterior Uveitis Drug Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia Anterior Uveitis Drug Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia Anterior Uveitis Drug Revenue (Million USD) Status 2016-2021
Figure 59: India Anterior Uveitis Drug Sales (K Units) Status 2016-2021
Figure 60: India Anterior Uveitis Drug Revenue (Million USD) Status 2016-2021
Figure 61: Australia Anterior Uveitis Drug Sales (K Units) Status 2016-2021
Figure 62: Australia Anterior Uveitis Drug Revenue (Million USD) Status 2016-2021
Figure 63: South America Anterior Uveitis Drug Sales Market Share by Country, 2020
Figure 64: South America Anterior Uveitis Drug Revenue Market Share by Country, 2020
Figure 65: Brazil Anterior Uveitis Drug Sales (K Units) Status 2016-2021
Figure 66: Brazil Anterior Uveitis Drug Revenue (Million USD) Status 2016-2021
Figure 67: Argentina Anterior Uveitis Drug Sales (K Units) Status 2016-2021
Figure 68: Argentina Anterior Uveitis Drug Revenue (Million USD) Status 2016-2021
Figure 69: Colombia Anterior Uveitis Drug Sales (K Units) Status 2016-2021
Figure 70: Colombia Anterior Uveitis Drug Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa Anterior Uveitis Drug Sales Market Share by Country, 2020
Figure 72: Middle East and Africa Anterior Uveitis Drug Revenue Market Share by Country, 2020
Figure 73: Turkey Anterior Uveitis Drug Sales (K Units) Status 2016-2021
Figure 74: Turkey Anterior Uveitis Drug Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia Anterior Uveitis Drug Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia Anterior Uveitis Drug Revenue (Million USD) Status 2016-2021
Figure 77: South Africa Anterior Uveitis Drug Sales (K Units) Status 2016-2021
Figure 78: South Africa Anterior Uveitis Drug Revenue (Million USD) Status 2016-2021
Figure 79: Neuroptis Biotech Anterior Uveitis Drug Revenue Market Share Globally (2019-2021)
Figure 80: KPI Therapeutics, Inc. Anterior Uveitis Drug Revenue Market Share Globally (2019-2021)
Figure 81: EyeGate Pharmaceuticals, Inc. Anterior Uveitis Drug Revenue Market Share Globally (2019-2021)
Figure 82: Aldeyra Therapeutics, Inc. Anterior Uveitis Drug Revenue Market Share Globally (2019-2021)
Figure 83: Aciont Inc. Anterior Uveitis Drug Revenue Market Share Globally (2019-2021)
Figure 89: Global Anterior Uveitis Drug Sales (K Units) Forecast (2022-2027)
Figure 90: Global Anterior Uveitis Drug Sales (K Units) Forecast (2022-2027)

Select User License

$3980 Single Licence
$5950 Enterprise Licence
$7960 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries